drugset / Trial / NCT06519786

Safety and Efficacy of Metformin for Treatment of Cytopenia in Children and Adolescents With Fanconi Anemia

NCT06519786 ↗

Phase 3 Unknown 30 enrolled Ain Shams University
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

Prospective interventional open-label non-randomized controlled trial to assess safety and efficacy of metformin in treating cytopenia in children and adolescents with Fanconi Anemia.

Timeline

Start
2022-10-05
Primary completion
2024-10
Completion
2025-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral
Subject Metformin Small molecule 1000 mg Oral

Indications